A hospital-based study of clinical and genetic features of Crohn's disease

Journal of the Formosan Medical Association

Volumn 110, Issue 9, 2011, Pages 600-606

  Wei, Shu Chen ^a   Ni, Yen Hsuan ^a   Yang, Hwai I ^b   Su, Yi Nin ^a   Chang, Ming Chu ^a   Chang, Yu Ting ^a   Shieh, Ming Jium ^a   Wang, Cheng Yi ^a   Wong, Jau Min ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

ATG16L1; Crohn's disease; Genetics; Taiwan; TNFSF15

Indexed keywords

CHEMOKINE RECEPTOR CCR6; CYTOKINE; GENOMIC DNA; INTERLEUKIN 12; INTERLEUKIN 23 RECEPTOR; LEUCINE RICH REPEAT KINASE 2; PROTEIN; PROTEIN ATG16L1; TUMOR NECROSIS FACTOR SUPERFAMILY MEMBER 2; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DATA BASE; DIAGNOSTIC IMAGING; FEMALE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HEREDITY; HUMAN; INTESTINE ENDOSCOPY; INTESTINE STENOSIS; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SURGICAL MORTALITY; TAIWAN;

ADOLESCENT; ADULT; AGED; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; FEMALE; HAPLOTYPES; HUMANS; INFANT; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 80052948694     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2011.07.009     Document Type: Article

References (45)

1. Himmel M.E., Hardenberg G., Piccirillo C.A., Steiner T.S., Levings M.K. The role of T-regulatory cells and toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology 2008, 125:145-153.
2. Barrett J.C., Hansoul S., Nicolae D.L., Cho J.H., Duerr R.H., Rioux J.D., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40:955-962.
3. Lee G.H., Kim C.G., Kim J.S., Jung H.C., Song I.S. Frequency analysis of NOD2 gene mutations in Korean patients with Crohn's disease. Korean J Gastroenterol 2005, 45:162-168. [in Korean].
4. Hsiao C.H., Wei S.C., Wong J.M., Lai H.S., Chang M.H., Ni Y.H. Pediatric Crohn disease: clinical and genetic characteristics in Taiwan. J Pediatr Gastroenterol Nutr 2007, 44:342-346.
5. Li M., Gao X., Guo C.C., Wu K.C., Zhang X., Hu P.J. OCTN and CARD15 gene polymorphism in Chinese patients with inflammatory bowel disease. World J Gastroenterol 2008, 14:4923-4927.
6. Yamazaki K., Takazoe M., Tanaka T., Kazumori T., Nakamura Y. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet 2002, 47:469-472.
7. Tsai C.H., Chen H.L., Ni Y.H., Hsu H.Y., Jeng Y.M., Chang C.J., et al. Characteristics and trends in incidence of inflammatory bowel disease in Taiwanese children. J Formos Med Assoc 2004, 103:685-691.
8. Balding J., Livingstone W.J., Conroy J., Mynett-Johnson L., Weir D.G., Mahmud N., et al. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm 2004, 13:181-187.
9. Cantor M.J., Nickerson P., Bernstein C.N. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am J Gastroenterol 2005, 100:1134-1142.
10. Dalal I., Karban A., Wine E., Eliakim R., Shirin H., Fridlender M., et al. Polymorphisms in the TNF-alpha promoter and variability in the granulomatous response in patients with Crohn's disease. Pediatr Res 2006, 59:825-828.
11. Gazouli M., Mantzaris G., Kotsinas A., Zacharatos P., Papalambros E., Archimandritis A., et al. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 2005, 11:681-685.
12. Gonzalez S., Rodrigo L., Martinez-Borra J., Lopez-Vazquez A., Fuentes D., Nino P., et al. TNF-alpha-308A promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients with fistulizing disease. Am J Gastroenterol 2003, 98:1101-1106.
13. Klein W., Tromm A., Griga T., Fricke H., Folwaczny C., Hocke M., et al. A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol 2002, 37:189-191.
14. Levine A., Karban A., Eliakim R., Shaoul R., Reif S., Pacht A., et al. A polymorphism in the TNF-alpha promoter gene is associated with pediatric onset and colonic location of Crohn's disease. Am J Gastroenterol 2005, 100:407-413.
15. Matsukura H., Ikeda S., Yoshimura N., Takazoe M., Muramatsu M. Genetic polymorphisms of tumour necrosis factor receptor superfamily 1A and 1B affect responses to infliximab in Japanese patients with Crohn's disease. Aliment Pharmacol Ther 2008, 27:765-770.
16. Sykora J., Subrt I., Didek P., Siala K., Schwarz J., Machalova V., et al. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G→A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 2006, 42:479-487.
17. Waschke K.A., Villani A.C., Vermeire S., Dufresne L., Chen T.C., Bitton A., et al. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes. Am J Gastroenterol 2005, 100:1126-1133.
18. Yamazaki K., Onouchi Y., Takazoe M., Kubo M., Nakamura Y., Hata A. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients. J Hum Genet 2007, 52:575-583.
19. Yang S.K., Lee S.G., Cho Y.K., Lim J., Lee I., Song K. Association of TNF-alpha/LTA polymorphisms with Crohn's disease in Koreans. Cytokine 2006, 35:13-20.
20. Zipperlen K., Peddle L., Melay B., Hefferton D., Rahman P. Association of TNF-alpha polymorphisms in Crohn disease. Hum Immunol 2005, 66:56-59.
21. Yamazaki K., McGovern D., Ragoussis J., Paolucci M., Butler H., Jewell D., et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 2005, 14:3499-3506.
22. Ouyang Q., Tandon R., Goh K.L., Pan G.Z., Fock K.M., Fiocchi C., et al. Management consensus of inflammatory bowel disease for the Asia-Pacific region. J Gastroenterol Hepatol 2006, 21:1772-1782.
23. Thia K.T., Loftus E.V., Sandborn W.J., Yang S.K. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008, 103:3167-3182.
24. Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007, 39:207-211.
25. Amre D.K., Mack D.R., Morgan K., Krupoves A., Costea I., Lambrette P., et al. Autophagy gene ATG16L1 but not IRGM is associated with Crohn's disease in Canadian children. Inflamm Bowel Dis 2009, 15:501-507.
26. Fowler E.V., Doecke J., Simms L.A., Zhao Z.Z., Webb P.M., Hayward N.K., et al. ATG16L1 T300A shows strong associations with disease subgroups in a large Australian IBD population: further support for significant disease heterogeneity. Am J Gastroenterol 2008, 103:2519-2526.
27. Glas J., Konrad A., Schmechel S., Dambacher J., Seiderer J., Schroff F., et al. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population. Am J Gastroenterol 2008, 103:682-691.
28. Lakatos P.L., Szamosi T., Szilvasi A., Molnar E., Lakatos L., Kovacs A., et al. ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients. Dig Liver Dis 2008, 40:867-873.
29. Latiano A., Palmieri O., Valvano M.R., D'Inca R., Cucchiara S., Riegler G., et al. Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy. World J Gastroenterol 2008, 14:4643-4651.
30. Newman W.G., Zhang Q., Liu X., Amos C.I., Siminovitch K.A. Genetic variants in IL-23R and ATG16L1 independently predispose to increased susceptibility to Crohn's disease in a Canadian population. J Clin Gastroenterol 2009, 43:444-447.
31. Perricone C., Borgiani P., Romano S., Ciccacci C., Fusco G., Novelli G., et al. ATG16L1 Ala197Thr is not associated with susceptibility to Crohn's disease or with phenotype in an Italian population. Gastroenterology 2008, 134:368-370.
32. Roberts R.L., Gearry R.B., Hollis-Moffatt J.E., Miller A.L., Reid J., Abkevich V., et al. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Am J Gastroenterol 2007, 102:2754-2761.
33. Baptista M.L., Amarante H., Picheth G., Sdepanian V.L., Peterson N., Babasukumar U., et al. CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population. Inflamm Bowel Dis 2008, 14:674-679.
34. Yang S.K., Park M., Lim J., Park S.H., Ye B.D., Lee I., et al. Contribution of IL23R but not ATG16L1 to Crohn's disease susceptibility in Koreans. Inflamm Bowel Dis 2009, 15:1385-1390.
35. Zhi J., Zhi F.C., Chen Z.Y., Yao G.P., Guan J., Lin Y., et al. Correlation of the autophagosome gene ATG16L1 polymorphism and inflammatory bowel disease. Nan Fang Yi Ke Da Xue Xue Bao 2008, 28:649-651. [in Chinese].
36. Kuballa P., Huett A., Rioux J.D., Daly M.J., Xavier R.J. Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant. PLoS ONE 2008, 3:e3391.
37. Thiebaut R., Kotti S., Jung C., Merlin F., Colombel J.F., Lemann M., et al. TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort. Am J Gastroenterol 2009, 104:384-391.
38. Yang S.K., Lim J., Chang H.S., Lee I., Li Y., Liu J., et al. Association of TNFSF15 with Crohn's disease in Koreans. Am J Gastroenterol 2008, 103:1437-1442.
39. Michelsen K.S., Thomas L.S., Taylor K.D., Yu Q.T., Mei L., Landers C.J., et al. IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein. PLoS ONE 2009, 4:e4719.
40. Kakuta Y., Ueki N., Kinouchi Y., Negoro K., Endo K., Nomura E., et al. TNFSF15 transcripts from risk haplotype for Crohn's disease are overexpressed in stimulated T cells. Hum Mol Genet 2009, 18:1089-1098.
41. Oriuchi T., Hiwatashi N., Kinouchi Y., Takahashi S., Takagi S., Negoro K., et al. Clinical course and longterm prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality. J Gastroenterol 2003, 38:942-953.
42. Park J.B., Yang S.K., Myung S.J., Byeon J.S., Lee Y.J., Lee G.H., et al. Clinical characteristics at diagnosis and course of Korean patients with Crohn's disease. Korean J Gastroenterol 2004, 43:8-17. [in Korean].
43. Law N.M., Lim C.C., Chong R., Ng H.S. Crohn's disease in the Singapore Chinese population. J Clin Gastroenterol 1998, 26:27-29.
44. Jiang L., Xia B., Li J., Ye M., Yan W., Deng C., et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis 2006, 12:212-217.
45. Leong R.W., Lau J.Y., Sung J.J. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis 2004, 10:646-651.